MedPath

Intraoperative electronic brachytherapy for high-grade gliomas with the XOFT® Axxent Electronic Brachytherapy System

Conditions
C71
Malignant neoplasm of brain
Registration Number
DRKS00022980
Lead Sponsor
Städtische Klinikum Dessau
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
36
Inclusion Criteria

Radiologically diagnosed high-grade glioma with confirmation in rapid cutting

Exclusion Criteria

Positive pregnancy test
Lack of consent of the patient or his legal representative
Rheumatoid arthritis, systemic lupus erythematosus, scleroderma

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
progression-free survival (PFS)
Secondary Outcome Measures
NameTimeMethod
Overall survival<br>Late toxicity according to the Common Terminology Criteria for Adverse Events of the National Cancer Institute, version 4.0<br>Quality of life as measured by QLQ-C30
© Copyright 2025. All Rights Reserved by MedPath